PPARβ Regulates Liver Regeneration by Modulating Akt and E2f Signaling

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Liu, Hui Xin ^a   Fang, Yaping ^b   Hu, Ying ^a   Gonzalez, Frank J ^c   Fang, Jianwen ^b   Wan, Yu Jui Yvonne ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; TRANSCRIPTION FACTOR E2F; TRANSCRIPTOME; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; TRANSCRIPTION FACTOR E2F2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME INACTIVATION; ENZYME REGULATION; FATTY ACID SYNTHESIS; GENE EXPRESSION; GLYCOLYSIS; LIVER REGENERATION; LIVER RESECTION; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEFICIENCY; REGULATORY MECHANISM; RNA SEQUENCE; SIGNAL TRANSDUCTION; STEATOSIS; ANIMAL; C57BL MOUSE; GENE EXPRESSION PROFILING; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

MUS;

ANIMALS; E2F2 TRANSCRIPTION FACTOR; GENE EXPRESSION PROFILING; GLYCOLYSIS; LIVER REGENERATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PPAR-BETA; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84879146244     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065644     Document Type: Article

References (42)

1. Yang X, Guo M, Wan YJ, (2010) Deregulation of growth factor, circadian clock, and cell cycle signaling in regenerating hepatocyte RXRα-deficient mouse livers. Am J Pathol 176: 733-743.
2. Aguilar V, Fajas L, (2010) Cycling through metabolism. EMBO Mol Med 2: 338-348.
3. Wang YX, (2010) PPARs: diverse regulators in energy metabolism and metabolic diseases. Cell Res 20: 124-137.
4. Wagner KD, Wagner N, (2010) Peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) acts as regulator of metabolism linked to multiple cellular functions. Pharmacol Ther 125: 423-435.
5. Vacca M, Degirolamo C, Massafra V, Polimeno L, Mariani-Costantini R, et al. (2012) Nuclear receptors in regenerating liver and hepatocellular carcinoma. Mol Cell Endocrinol 368: 108-119.
6. Anderson SP, Yoon L, Richard EB, Dunn CS, Cattley RC, et al. (2002) Delayed liver regeneration in peroxisome proliferator-activated receptor-α-null mice. Hepatology 36: 544-554.
7. Rao M, Peters JM, Gonzalez FJ, Reddy JK, (2002) Hepatic regeneration in peroxisome proliferator-activated receptor α-null mice after partial hepatectomy. Hepatol Res 22: 52-57.
8. Wheeler MD, Smutney OM, Check JF, Rusyn I, Schulte-Hermann R, et al. (2003) Impaired Ras membrane association and activation in PPAR α knockout mice after partial hepatectomy. Am J Physiol-Gastr L 284: G302-G312.
9. Skrtic S, Carlsson L, Ljungberg A, Linden D, Michalik L, et al. (2005) Decreased expression of peroxisome proliferator-activated receptor α and liver fatty acid binding protein after partial hepatectomy of rats and mice. Liver Int 25: 33-40.
10. Gazit V, Huang J, Weymann A, Rudnick DA, (2012) Analysis of the role of hepatic PPARγ expression during mouse liver regeneration. Hepatology 56: 1489-1498.
11. Yuan X, Yan SK, Zhao J, Shi D, Yuan B, et al. (2011) Lipid Metabolism and Peroxisome Proliferator-Activated Receptor Signaling Pathways Participate in Late-Phase Liver Regeneration. J Proteome Res 10: 1179-1190.
12. Qu A, Shah YM, Matsubara T, Yang Q, Gonzalez FJ, (2010) PPARα-dependent activation of cell cycle control and DNA repair genes in hepatic nonparenchymal cells. Toxicol Sci 118: 404-410.
13. Yamamoto Y, Ono T, Dhar DK, Yamanoi A, Tachibana M, et al. (2008) Role of peroxisome proliferator-activated receptor-gamma (PPARγ) during liver regeneration in rats. J Gastroen Hepatol 23: 930-937.
14. Zingarelli B, Piraino G, Hake PW, O'Connor M, Denenberg A, et al. (2010) Peroxisome proliferator-activated receptor {delta} regulates inflammation via NF-{kappa}B signaling in polymicrobial sepsis. Am J Pathol 177: 1834-1847.
15. Shan W, Palkar PS, Murray IA, McDevitt EI, Kennett MJ, et al. (2008) Ligand activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression. Toxicol Sci 105: 418-428.
16. Kostadinova R, Montagner A, Gouranton E, Fleury S, Guillou H, et al. (2012) GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation. Cell and Bioscience 2: 34.
17. Di-Poï N, Tan NS, Michalik L, Wahli W, Desvergne B, (2002) Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol Cell 10: 721-733.
18. Tsuji K, Mitsutake S, Yokose U, Sugiura M, Kohama T, et al. (2008) Role of ceramide kinase in peroxisome proliferator-activated receptor beta-induced cell survival of mouse keratinocytes. FEBS J 275: 3815-3826.
19. Borland MG, Foreman JE, Girroir EE, Zolfaghari R, Sharma AK, et al. (2008) Ligand activation of peroxisome proliferator-activated receptor-β/δ inhibits cell proliferation in human HaCaT keratinocytes. Mol Pharmacol 74: 1429-1442.
20. Stephen RL, Gustafsson MC, Jarvis M, Tatoud R, Marshall BR, et al. (2004) Activation of peroxisome proliferator-activated receptor δ stimulates the proliferation of human breast and prostate cancer cell lines. Cancer Res 64: 3162-3170.
21. He PF, Borland MG, Zhu BA, Sharma AK, Amin S, et al. (2008) Effect of ligand activation of peroxisome proliferator-activated receptor- β/δ (PPARβ/δ) in human lung cancer cell lines. Toxicology 254: 112-117.
22. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, et al. (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature Protocols 7: 562-578.
23. Burdick AD, Bility MT, Girroir EE, Billin AN, Willson TM, et al. (2007) Ligand activation of peroxisome proliferator-activated receptor- β/δ (PPARβ/δ) inhibits cell growth of human N/TERT-1 keratinocytes. Cell Signal 19: 1163-1171.
24. Gille H, Downward J, (1999) Multiple ras effector pathways contribute to G(1) cell cycle progression. J Biol Chem 274: 22033-22040.
25. Huang TH, Roufogalis BD, (2012) Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs). Curr Mol Pharmacol 5: 241-247.
26. Vosper H, Patel L, Graham TL, Khoudoli GA, Hill A, et al. (2001) The peroxisome proliferator-activated receptor δ promotes lipid accumulation in human macrophages. J Biol Chem 276: 44258-44265.
27. Barak Y, Liao D, He WM, Ong ES, Nelson MC, et al. (2002) Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer. P Natl Acad Sci USA 99: 303-308.
28. Romanowska M, Al Yacoub N, Seidel H, Donandt S, Gerken H, et al. (2008) PPARdelta enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor. J Invest Dermatol 128: 110-124.
29. Borland MG, Foreman JE, Girroir EE, Zolfaghari R, Sharma AK, et al. (2008) Ligand Activation of Peroxisome Proliferator-Activated Receptor-beta/delta Inhibits Cell Proliferation in Human HaCaT Keratinocytes. Molecular Pharmacology 74: 1429-1442.
30. Fajas L, Annicotte JS, Miard S, Sarruf D, Watanabe M, et al. (2004) Impaired pancreatic growth, beta cell mass, and beta cell function in E2F1(-/-) mice. J Clin Invest 113: 1288-1295.
31. Porstmann T, Griffiths B, Chung YL, Delpuech O, Jr G, et al. (2005) PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 24: 6465-6481.
32. Fritz V, Fajas L, (2010) Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene 29: 4369-4377.
33. Buzzai M, Bauer DE, Jones RG, DeBerardinis RJ, Hatzivassiliou G, et al. (2005) The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene 24: 4165-4173.
34. Zhou Y, Zhang X, Chen L, Wu J, Dang H, et al. (2008) Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats. Am J Physiol-Renal 295: F662-F671.
35. Blanchet E, Annicotte JS, Lagarrigue S, Aguilar V, Clape C, et al. (2011) E2F transcription factor-1 regulates oxidative metabolism. Nat Cell Biol 13: 1146-U1184.
36. Hallstrom TC, Mori S, Nevins JR, (2008) An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 13: 11-22.
37. Lukas ER, Bartley SM, Graveel CR, Diaz ZM, Dyson N, et al. (1999) No effect of loss of E2F1 on liver regeneration or hepatocarcinogenesis in C57BL/6J or C3H/HeJ mice. Mol Carcinog 25: 295-303.
38. Annicotte JS, Blanchet E, Chavey C, Iankova I, Costes S, et al. (2009) The CDK4-pRB-E2F1 pathway controls insulin secretion. Nat Cell Biol 11: 1017-U1247.
39. Cicenas J, Urban P, Vuaroqueaux V, Labuhn M, Kung W, et al. (2005) Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2. Breast Cancer Research 7: R394-R401.
40. Siersbaek R, Nielsen R, John S, Sung MH, Baek S, et al. (2011) Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J 30: 1459-1472.
41. Fajas L, Landsberg RL, Huss-Garcia Y, Sardet C, Lees JA, et al. (2002) E2Fs regulate adipocyte differentiation. Dev Cell 3: 39-49.
42. Leclercq IA, Field J, Farrell GC, (2003) Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury. Gastroenterology 124: 1451-1464.